Biocon is currently trading at Rs. 235.00, up by 5.05 points or 2.20% from its previous closing of Rs. 229.95 on the BSE.
The scrip opened at Rs. 229.00 and has touched a high and low of Rs. 238.50 and Rs. 225.75 respectively. So far 2,75,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 388.05 on 28-Apr-2011 and a 52 week low of Rs. 225.75 on 27-Apr-2012.
Last one week high and low of the scrip stood at Rs. 245.45 and Rs. 225.75 respectively. The current market cap of the company is Rs. 4,700.00 crore.
The promoters holding in the company stood at 60.91% while Institutions and Non-Institutions held 12.18% and 26.91% respectively.
On the standalone basis, the company has posted a fall of 29.18% in its net profit at Rs 62.34 crore for the quarter ended March 31, 2012 as compared to Rs 88.03 crore for the same quarter in the previous year. However total income has increased by 14.40% at Rs 432.60 crore for quarter under review as compared to Rs 378.15 crore for the quarter ended March 31, 2011.
On the consolidated basis, the company has posted a fall of 2.99% in its net profit at Rs 97.80 crore for the quarter ended March 31, 2012 as compared to Rs 100.81 crore for the same quarter in the previous year. However total income has increased by 29.60% at Rs 610.20 crore for quarter under review as compared to Rs 470.85 crore for the quarter ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |